{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:19:59Z","timestamp":1788520799443,"version":"build-2803163510"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T00:00:00Z","timestamp":1450051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12035-015-9560-0","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T06:19:41Z","timestamp":1450073981000},"page":"6897-6909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review"],"prefix":"10.1007","volume":"53","author":[{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"9560_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494\u2013500","journal-title":"N Engl J Med"},{"key":"9560_CR2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036\u20131042","journal-title":"AJNR Am J Neuroradiol"},{"key":"9560_CR3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/B978-0-7020-4088-7.00109-7","volume":"121","author":"C Lamy","year":"2014","unstructured":"Lamy C, Oppenheim C, Mas JL (2014) Posterior reversible encephalopathy syndrome. Handb Clin Neurol 121:1687\u20131701","journal-title":"Handb Clin Neurol"},{"key":"9560_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0885066610393634","volume":"27","author":"D Staykov","year":"2012","unstructured":"Staykov D, Schwab S (2012) Posterior reversible encephalopathy syndrome. J Intensive Care Med 27:11\u201324","journal-title":"J Intensive Care Med"},{"key":"9560_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000319032","volume":"64","author":"Q Wu","year":"2010","unstructured":"Wu Q, Marescaux C, Wolff V, Jeung MY, Kessler R, Lauer V, Chen Y (2010) Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation. Eur Neurol 64:169\u2013177","journal-title":"Eur Neurol"},{"key":"9560_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.transproceed.2005.12.113","volume":"38","author":"AM Agildere","year":"2006","unstructured":"Agildere AM, Basaran C, Cakir B, Ozgul E, Kural F, Haberal M (2006) Evaluation of neurologic complications by brain MRI in kidney and liver transplant recipients. Transplant Proc 38:611\u2013618","journal-title":"Transplant Proc"},{"key":"9560_CR7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2214\/AJR.07.2024","volume":"189","author":"AM McKinney","year":"2007","unstructured":"McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189:904\u2013912","journal-title":"AJR Am J Roentgenol"},{"key":"9560_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/0971-4065.109439","volume":"23","author":"S Alexander","year":"2013","unstructured":"Alexander S, David VG, Varughese S, Tamilarasi V, Jacob CK (2013) Posterior reversible encephalopathy syndrome in a renal allograft recipient: a complication of immunosuppression? Indian J Nephrol 23:137\u2013139","journal-title":"Indian J Nephrol"},{"key":"9560_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.12659\/AJCR.889260","volume":"14","author":"M Alparslan","year":"2013","unstructured":"Alparslan M, Bora U, Huseyin K, Ayhan D, Gultekin S (2013) Posterior reversible encephalopathy syndrome in a renal transplanted patient. Am J Case Rep 14:241\u2013244","journal-title":"Am J Case Rep"},{"key":"9560_CR10","doi-asserted-by":"crossref","first-page":"e2014014","DOI":"10.4084\/mjhid.2014.014","volume":"6","author":"S Apuri","year":"2014","unstructured":"Apuri S, Carlin K, Bass E, Nguyen PT, Greene JN (2014) Tacrolimus associated posterior reversible encephalopathy syndrome\u2014a case series and review. Mediterr J Hematol Infect Dis 6:e2014014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"9560_CR11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.transproceed.2014.05.032","volume":"46","author":"FE Arimura","year":"2014","unstructured":"Arimura FE, Camargo PC, Costa AN, Teixeira RH, Carraro RM, Afonso JE Jr, Campos SV, Samano MN et al (2014) Posterior reversible encephalopathy syndrome in lung transplantation: 5 case reports. Transplant Proc 46:1845\u20131848","journal-title":"Transplant Proc"},{"key":"9560_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.yebeh.2010.01.014","volume":"17","author":"M Baldini","year":"2010","unstructured":"Baldini M, Bartolini E, Gori S, Bonanni E, Cosottini M, Iudice A, Murri L (2010) Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome. Epilepsy Behav 17:558\u2013560","journal-title":"Epilepsy Behav"},{"key":"9560_CR13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ajt.12061","volume":"13","author":"AS Barbas","year":"2013","unstructured":"Barbas AS, Rege AS, Castleberry AW, Gommer J, Ellis MJ, Brennan TV, Collins BH, Martin AE et al (2013) Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 13:808\u2013810","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"9560_CR14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/pbc.23344","volume":"58","author":"DM Cordelli","year":"2012","unstructured":"Cordelli DM, Masetti R, Bernardi B, Barcia G, Gentile V, Biagi C, Prete A, Pession A et al (2012) Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer 58:785\u2013790","journal-title":"Pediatr Blood Cancer"},{"key":"9560_CR15","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1600-6143.2012.04048.x","volume":"12","author":"RJ Cruz Jr","year":"2012","unstructured":"Cruz RJ Jr, DiMartini A, Akhavanheidari M, Iacovoni N, Boardman JF, Donaldson J, Humar A, Bartynski WS (2012) Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 12:2228\u20132236","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"9560_CR16","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1111\/j.1399-3046.2010.01358.x","volume":"15","author":"T Fukuyama","year":"2011","unstructured":"Fukuyama T, Tanaka M, Nakazawa Y, Motoki N, Inaba Y, Higuchi T, Koike K (2011) Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome. Pediatr Transplant 15:E169\u2013E173","journal-title":"Pediatr Transplant"},{"key":"9560_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajh.23402","volume":"88","author":"AE Hammerstrom","year":"2013","unstructured":"Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U (2013) Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 88:301\u2013305","journal-title":"Am J Hematol"},{"key":"9560_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pediatrneurol.2013.11.006","volume":"50","author":"D Hayes Jr","year":"2014","unstructured":"Hayes D Jr, Adler B, Turner TL, Mansour HM (2014) Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. Pediatr Neurol 50:272\u2013275","journal-title":"Pediatr Neurol"},{"key":"9560_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08880010903420661","volume":"27","author":"S Heo","year":"2010","unstructured":"Heo S, Cho HJ, Jeon IS (2010) A case of posterior reversible encephalopathy syndrome in a child with myelodysplastic syndrome following allogenic bone marrow transplantation. Pediatr Hematol Oncol 27:59\u201364","journal-title":"Pediatr Hematol Oncol"},{"key":"9560_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.hemonc.2013.05.002","volume":"6","author":"S Jennane","year":"2013","unstructured":"Jennane S, el Mahtat M, Konopacki J, Malfuson JV, Doghmi K, Mikdame M, De Revel T (2013) Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation. Hematol Oncol Stem Cell Ther 6:71","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"9560_CR21","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1111\/petr.12039","volume":"17","author":"RW Loar","year":"2013","unstructured":"Loar RW, Patterson MC, O\u2019Leary PW, Driscoll DJ, Johnson JN (2013) Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient. Pediatr Transplant 17:E67\u2013E70","journal-title":"Pediatr Transplant"},{"key":"9560_CR22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009734.2013.842618","volume":"119","author":"D Moris","year":"2014","unstructured":"Moris D, Vernadakis S, Lionaki S, Daikos G, Zavos G (2014) An uncommon cause of acutely altered mental status in a renal transplant recipient. Ups J Med Sci 119:50\u201354","journal-title":"Ups J Med Sci"},{"key":"9560_CR23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11255-010-9757-0","volume":"43","author":"W Qin","year":"2011","unstructured":"Qin W, Tan CY, Huang X, Huang Z, Tao Y, Fu P (2011) Rapamycin-induced posterior reversible encephalopathy in a kidney transplantation patient. Int Urol Nephrol 43:913\u2013916","journal-title":"Int Urol Nephrol"},{"key":"9560_CR24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.transproceed.2012.06.027","volume":"44","author":"L Rosso","year":"2012","unstructured":"Rosso L, Nosotti M, Mendogni P, Palleschi A, Tosi D, Montoli M, Pappalettera M, Tarsia P et al (2012) Lung transplantation and posterior reversible encephalopathy syndrome: a case series. Transplant Proc 44:2022\u20132025","journal-title":"Transplant Proc"},{"key":"9560_CR25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1399-3046.2010.01430.x","volume":"15","author":"MM Santos","year":"2011","unstructured":"Santos MM, Tannuri AC, Gibelli NE, Ayoub AA, Maksoud-Filho JG, Andrade WC, Velhote MC, Silva MM et al (2011) Posterior reversible encephalopathy syndrome after liver transplantation in children: a rare complication related to calcineurin inhibitor effects. Pediatr Transplant 15:157\u2013160","journal-title":"Pediatr Transplant"},{"key":"9560_CR26","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/TP.0b013e31826dde21","volume":"94","author":"X Shao","year":"2012","unstructured":"Shao X, He Z, Tang L, Gao L (2012) Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. Transplantation 94:e58\u2013e60","journal-title":"Transplantation"},{"key":"9560_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11748-012-0030-6","volume":"60","author":"T Shoji","year":"2012","unstructured":"Shoji T, Bando T, Fujinaga T, Chen F, Kohno M, Yabe M, Yabe H, Date H (2012) Posterior reversible encephalopathy syndrome due to immunosuppressant after living-donor lobar lung transplantation: report of a case. Gen Thorac Cardiovasc Surg 60:514\u2013517","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"9560_CR28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.leukres.2011.02.022","volume":"35","author":"GF Torelli","year":"2011","unstructured":"Torelli GF, Natalino F, Barberi W, Iori AP, Andreoli C, Valle V, Mercanti C, Perrone S et al (2011) Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion. Leuk Res 35:1423\u20131424","journal-title":"Leuk Res"},{"key":"9560_CR29","first-page":"387","volume":"60","author":"N Ueda","year":"2014","unstructured":"Ueda N, Kawamura M, Nakazawa S, Hirai T, Kishikawa H, Nishimura K (2014) Posterior reversible encephalopathy syndrome (PRES) after kidney transplantation: a case report. Hinyokika Kiyo Acta Urologica Jpn 60:387\u2013392","journal-title":"Hinyokika Kiyo Acta Urologica Jpn"},{"key":"9560_CR30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pediatrneurol.2010.05.021","volume":"43","author":"S Yilmaz","year":"2010","unstructured":"Yilmaz S, Gokben S, Arikan C, Calli C, Serdaroglu G (2010) Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy. Pediatr Neurol 43:359\u2013362","journal-title":"Pediatr Neurol"},{"key":"9560_CR31","doi-asserted-by":"crossref","unstructured":"Zaman S R (2012) Posterior reversible encephalopathy syndrome postautologous peripheral stem cell transplantation for multiple myeloma. BMJ Case Rep 2012","DOI":"10.1136\/bcr-2012-006331"},{"key":"9560_CR32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3174\/ajnr.A0960","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW (2008) Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 29:924\u2013930","journal-title":"AJNR Am J Neuroradiol"},{"key":"9560_CR33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2141.2003.04447.x","volume":"122","author":"R Wong","year":"2003","unstructured":"Wong R, Beguelin GZ, de Lima M, Giralt SA, Hosing C, Ippoliti C, Forman AD, Kumar AJ et al (2003) Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 122:128\u2013134","journal-title":"Br J Haematol"},{"key":"9560_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-15-10","volume":"15","author":"BR Graham","year":"2014","unstructured":"Graham BR, Pylypchuk GB (2014) Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol 15:10","journal-title":"BMC Nephrol"},{"key":"9560_CR35","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2169\/internalmedicine.52.0444","volume":"52","author":"N Nakajima","year":"2013","unstructured":"Nakajima N, Ueda M, Nagayama H, Yamazaki M, Katayama Y (2013) Posterior reversible encephalopathy syndrome due to hypercalcemia associated with parathyroid hormone-related peptide: a case report and review of the literature. Intern Med 52:2465\u20132468","journal-title":"Intern Med"},{"key":"9560_CR36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1445-5994.2010.02314.x","volume":"40","author":"BK Tsang","year":"2010","unstructured":"Tsang BK, Kermeen FD, Hopkins PM, Chambers DC (2010) Reversible posterior leukoencephalopathy syndrome: diagnosis and management in the setting of lung transplantation. Int Med J 40:716\u2013720","journal-title":"Int Med J"},{"key":"9560_CR37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.03.011","volume":"21","author":"AA Rabinstein","year":"2012","unstructured":"Rabinstein AA, Mandrekar J, Merrell R, Kozak OS, Durosaro O, Fugate JE (2012) Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 21:254\u2013258","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"9560_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","volume":"85","author":"JE Fugate","year":"2010","unstructured":"Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427\u2013432","journal-title":"Mayo Clin Proc"},{"key":"9560_CR39","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3174\/ajnr.A1588","volume":"30","author":"HM Hefzy","year":"2009","unstructured":"Hefzy HM, Bartynski WS, Boardman JF, Lacomis D (2009) Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol 30:1371\u20131379","journal-title":"AJNR Am J Neuroradiol"},{"key":"9560_CR40","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.transproceed.2013.08.101","volume":"45","author":"C Araz","year":"2013","unstructured":"Araz C, Camkiran A, Zeyneloglu P, Sezgin A, Moray G, Pirat A, Arslan G (2013) Early-onset posterior reversible encephalopathy syndrome after solid organ transplantation in pediatric patients: a report of 2 cases. Transplant Proc 45:3555\u20133557","journal-title":"Transplant Proc"},{"key":"9560_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diii.2012.02.005","volume":"94","author":"E Hugonnet","year":"2013","unstructured":"Hugonnet E, Da Ines D, Boby H, Claise B, Petitcolin V, Lannareix V, Garcier JM (2013) Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imaging 94:45\u201352","journal-title":"Diagn Interv Imaging"},{"key":"9560_CR42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4254\/wjh.v5.i8.409","volume":"5","author":"SA Zivkovic","year":"2013","unstructured":"Zivkovic SA (2013) Neurologic complications after liver transplantation. World J Hepatol 5:409\u2013416","journal-title":"World J Hepatol"},{"key":"9560_CR43","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1259\/bjr\/25273221","volume":"85","author":"CJ Stevens","year":"2012","unstructured":"Stevens CJ, Heran MK (2012) The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 85:1566\u20131575","journal-title":"Br J Radiol"},{"key":"9560_CR44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MAJ.0b013e3181d3cd78","volume":"339","author":"JD King","year":"2010","unstructured":"King JD, Rosner MH (2010) Osmotic demyelination syndrome. Am J Medi Sci 339:561\u2013567","journal-title":"Am J Medi Sci"},{"key":"9560_CR45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.parkreldis.2013.04.005","volume":"19","author":"A Souza de","year":"2013","unstructured":"de Souza A (2013) Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord 19:709\u2013716","journal-title":"Parkinsonism Relat Disord"},{"key":"9560_CR46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.sult.2013.09.009","volume":"35","author":"AM Alleman","year":"2014","unstructured":"Alleman AM (2014) Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR 35:153\u2013159","journal-title":"Semin Ultrasound CT MR"},{"key":"9560_CR47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1227\/NEU.0b013e31828cf619","volume":"72","author":"W Lake","year":"2013","unstructured":"Lake W, Chang JE, Kennedy T, Morgan A, Salamat S, Baskaya MK (2013) A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics. Neurosurgery 72:960\u2013970, discussion 970","journal-title":"Neurosurgery"},{"key":"9560_CR48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12253-010-9329-8","volume":"17","author":"G Vegso","year":"2011","unstructured":"Vegso G, Hajdu M, Sebestyen A (2011) Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathol Oncol Res 17:443\u2013454","journal-title":"Pathol Oncol Res"},{"key":"9560_CR49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1941874412466090","volume":"3","author":"AA Pruitt","year":"2013","unstructured":"Pruitt AA, Graus F, Rosenfeld MR (2013) Neurological complications of solid organ transplantation. Neurohospitalist 3:152\u2013166","journal-title":"Neurohospitalist"},{"key":"9560_CR50","first-page":"3105","volume":"23","author":"JJ Fung","year":"1991","unstructured":"Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Van Thiel D, Armitage J et al (1991) Adverse effects associated with the use of FK 506. Transplant Proc 23:3105\u20133108","journal-title":"Transplant Proc"},{"key":"9560_CR51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/neup.12125","volume":"34","author":"E Hewer","year":"2014","unstructured":"Hewer E, Kellner-Weldon F, Abu-Isa J, Schmitt AM (2014) Multiple cerebral lesions in a 60-year-old female patient with a history of liver transplantation. Neuropathol Off J Jpn Soc Neuropathol 34:425\u2013427","journal-title":"Neuropathol Off J Jpn Soc Neuropathol"},{"key":"9560_CR52","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.humpath.2010.02.015","volume":"41","author":"Z Meriden","year":"2010","unstructured":"Meriden Z, Bullock GC, Bagg A, Bonatti H, Cousar JB, Lopes MB, Robbins MK, Cathro HP (2010) Posttransplantation lymphoproliferative disease involving the pituitary gland. Hum Pathol 41:1641\u20131645","journal-title":"Hum Pathol"},{"key":"9560_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9429-9","volume":"86","author":"JM Baehring","year":"2008","unstructured":"Baehring JM, Landry ML, Cooper D, Hui P, Bannykh S (2008) CSF IgH gene rearrangement analysis in isolated post-transplant lymphoproliferative disorder of the central nervous system. J Neuro-Oncol 86:57\u201360","journal-title":"J Neuro-Oncol"},{"key":"9560_CR54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crad.2010.03.001","volume":"65","author":"R Shah","year":"2010","unstructured":"Shah R, Bag AK, Chapman PR, Cure JK (2010) Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65:431\u2013439","journal-title":"Clin Radiol"},{"key":"9560_CR55","first-page":"1060","volume":"19","author":"MA Sahraian","year":"2012","unstructured":"Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A (2012) Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol Off J Eur Fed Neurol Soc 19:1060\u20131069","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"key":"9560_CR56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.clineuro.2012.06.018","volume":"114","author":"M Horger","year":"2012","unstructured":"Horger M, Beschorner R, Beck R, Nagele T, Schulze M, Ernemann U, Heckl S (2012) Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations. Clin Neurol Neurosurg 114:1123\u20131130","journal-title":"Clin Neurol Neurosurg"},{"key":"9560_CR57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1941874412455338","volume":"3","author":"AA Pruitt","year":"2013","unstructured":"Pruitt AA, Graus F, Rosenfeld MR (2013) Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist 3:24\u201338","journal-title":"Neurohospitalist"},{"key":"9560_CR58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2010.09.021","volume":"231","author":"R Weissert","year":"2011","unstructured":"Weissert R (2011) Progressive multifocal leukoencephalopathy. J Neuroimmunol 231:73\u201377","journal-title":"J Neuroimmunol"},{"key":"9560_CR59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1445-5994.2004.00750.x","volume":"35","author":"VL Stott","year":"2005","unstructured":"Stott VL, Hurrell MA, Anderson TJ (2005) Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Int Med J 35:83\u201390","journal-title":"Int Med J"},{"key":"9560_CR60","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.transproceed.2009.01.041","volume":"41","author":"A Dzudie","year":"2009","unstructured":"Dzudie A, Boissonnat P, Roussoulieres A, Cakmak, Mosbah K, Bejui FT, Obadia JF, Sebbag L (2009) Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports. Transplant Proc 41:716\u2013720","journal-title":"Transplant Proc"},{"key":"9560_CR61","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.transproceed.2006.02.038","volume":"38","author":"R Munoz","year":"2006","unstructured":"Munoz R, Espinoza M, Espinoza O, Andrade A, Bravo E, Gonzalez F (2006) Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases. Transplant Proc 38:921\u2013923","journal-title":"Transplant Proc"},{"key":"9560_CR62","first-page":"180","volume":"7","author":"C Heidenhain","year":"2009","unstructured":"Heidenhain C, Puhl G, Neuhaus P (2009) Late fulminant posterior reversible encephalopathy syndrome after liver transplant. Exp Clin Transplant Off J Middle East Soc Organ Transplant 7:180\u2013183","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant"},{"key":"9560_CR63","doi-asserted-by":"crossref","first-page":"g254","DOI":"10.1136\/bmj.g254","volume":"348","author":"D Schmidt","year":"2014","unstructured":"Schmidt D, Schachter SC (2014) Drug treatment of epilepsy in adults. BMJ 348:g254","journal-title":"BMJ"},{"key":"9560_CR64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.seizure.2010.05.008","volume":"19","author":"J Ruiz-Gimenez","year":"2010","unstructured":"Ruiz-Gimenez J, Sanchez-Alvarez JC, Canadillas-Hidalgo F, Serrano-Castro PJ, Andalusian Epilepsy S (2010) Antiepileptic treatment in patients with epilepsy and other comorbidities. Seizure 19:375\u2013382","journal-title":"Seizure"},{"key":"9560_CR65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jash.2011.06.001","volume":"5","author":"WS Aronow","year":"2011","unstructured":"Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M et al (2011) ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 5:259\u2013352","journal-title":"J Am Soc Hypertens"},{"key":"9560_CR66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-7020-4086-3.00012-6","volume":"119","author":"RS Price","year":"2014","unstructured":"Price RS, Kasner SE (2014) Hypertension and hypertensive encephalopathy. Handb Clin Neurol 119:161\u2013167","journal-title":"Handb Clin Neurol"},{"key":"9560_CR67","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.2009.189647","volume":"81","author":"C Roth","year":"2010","unstructured":"Roth C, Ferbert A (2010) Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry 81:773\u2013777","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9560_CR68","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.bbmt.2007.07.013","volume":"13","author":"D Siegal","year":"2007","unstructured":"Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, Lipton JH, Messner H et al (2007) Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 13:1369\u20131379","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"9560_CR69","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00467-003-1243-9","volume":"18","author":"N Prasad","year":"2003","unstructured":"Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK (2003) Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 18:1161\u20131166","journal-title":"Pediatr Nephrol"},{"key":"9560_CR70","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043\u20131049","journal-title":"AJNR Am J Neuroradiol"},{"key":"9560_CR71","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.crad.2007.08.006","volume":"63","author":"RA Dineen","year":"2008","unstructured":"Dineen RA, Sibtain N, Karani JB, Lenthall RK (2008) Cerebral manifestations in liver disease and transplantation. Clin Radiol 63:586\u2013599","journal-title":"Clin Radiol"},{"key":"9560_CR72","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-199754060-00009","volume":"54","author":"CM Spencer","year":"1997","unstructured":"Spencer CM, Goa KL, Gillis JC (1997) Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54:925\u2013975","journal-title":"Drugs"},{"key":"9560_CR73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12035-011-8184-2","volume":"44","author":"M Gerard","year":"2011","unstructured":"Gerard M, Deleersnijder A, Demeulemeester J, Debyser Z, Baekelandt V (2011) Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration. Mol Neurobiol 44:13\u201327","journal-title":"Mol Neurobiol"},{"key":"9560_CR74","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","volume":"80","author":"S Ho","year":"1996","unstructured":"Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40\u2013S45","journal-title":"Clin Immunol Immunopathol"},{"key":"9560_CR75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","volume":"59","author":"GL Plosker","year":"2000","unstructured":"Plosker GL, Foster RH (2000) Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59:323\u2013389","journal-title":"Drugs"},{"key":"9560_CR76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","volume":"13","author":"SL Schreiber","year":"1992","unstructured":"Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136\u2013142","journal-title":"Immunol Today"},{"key":"9560_CR77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2004.10.027","volume":"505","author":"S Dohgu","year":"2004","unstructured":"Dohgu S, Yamauchi A, Nakagawa S, Takata F, Kai M, Egawa T, Naito M, Tsuruo T et al (2004) Nitric oxide mediates cyclosporine-induced impairment of the blood\u2013brain barrier in cocultures of mouse brain endothelial cells and rat astrocytes. Eur J Pharmacol 505:51\u201359","journal-title":"Eur J Pharmacol"},{"key":"9560_CR78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0014-2999(99)00247-2","volume":"372","author":"S Kochi","year":"1999","unstructured":"Kochi S, Takanaga H, Matsuo H, Naito M, Tsuruo T, Sawada Y (1999) Effect of cyclosporin A or tacrolimus on the function of blood\u2013brain barrier cells. Eur J Pharmacol 372:287\u2013295","journal-title":"Eur J Pharmacol"},{"key":"9560_CR79","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(00)00554-3","volume":"66","author":"S Kochi","year":"2000","unstructured":"Kochi S, Takanaga H, Matsuo H, Ohtani H, Naito M, Tsuruo T, Sawada Y (2000) Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 66:2255\u20132260","journal-title":"Life Sci"},{"key":"9560_CR80","first-page":"51","volume":"2","author":"T Ozawa","year":"2008","unstructured":"Ozawa T (2008) Effects of FK506 on ca release channels (review). Perspect Med Chem 2:51\u201355","journal-title":"Perspect Med Chem"},{"key":"9560_CR81","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3760\/cma.j.issn.0366-6999.20141176","volume":"127","author":"J Wang","year":"2014","unstructured":"Wang J, Guo R, Liu S, Chen Q, Zuo S, Yang M, Zuo X (2014) Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. Chin Med J 127:3645\u20133650","journal-title":"Chin Med J"},{"key":"9560_CR82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0092-8674(95)90124-8","volume":"83","author":"AM Cameron","year":"1995","unstructured":"Cameron AM, Steiner JP, Roskams AJ, Ali SM, Ronnett GV, Snyder SH (1995) Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 83:463\u2013472","journal-title":"Cell"},{"key":"9560_CR83","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02740664","volume":"15","author":"BG Gold","year":"1997","unstructured":"Gold BG (1997) FK506 and the role of immunophilins in nerve regeneration. Mol Neurobiol 15:285\u2013306","journal-title":"Mol Neurobiol"},{"key":"9560_CR84","first-page":"39","volume":"3","author":"NJ Abbott","year":"1991","unstructured":"Abbott NJ, Revest PA (1991) Control of brain endothelial permeability. Cerebrovasc Brain Metab Rev 3:39\u201372","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"9560_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.001","volume":"108","author":"M Bock De","year":"2013","unstructured":"De Bock M, Wang N, Decrock E, Bol M, Gadicherla AK, Culot M, Cecchelli R, Bultynck G et al (2013) Endothelial calcium dynamics, connexin channels and blood\u2013brain barrier function. Prog Neurobiol 108:1\u201320","journal-title":"Prog Neurobiol"},{"key":"9560_CR86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP (2005) The blood\u2013brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57:173\u2013185","journal-title":"Pharmacol Rev"},{"key":"9560_CR87","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","volume":"24","author":"JD Huber","year":"2001","unstructured":"Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood\u2013brain barrier. Trends Neurosci 24:719\u2013725","journal-title":"Trends Neurosci"},{"key":"9560_CR88","doi-asserted-by":"crossref","first-page":"13636","DOI":"10.1074\/jbc.271.23.13636","volume":"271","author":"RO Stuart","year":"1996","unstructured":"Stuart RO, Sun A, Bush KT, Nigam SK (1996) Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J Biol Chem 271:13636\u201313641","journal-title":"J Biol Chem"},{"key":"9560_CR89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejphar.2010.05.035","volume":"644","author":"S Dohgu","year":"2010","unstructured":"Dohgu S, Sumi N, Nishioku T, Takata F, Watanabe T, Naito M, Shuto H, Yamauchi A et al (2010) Cyclosporin A induces hyperpermeability of the blood\u2013brain barrier by inhibiting autocrine adrenomedullin-mediated up-regulation of endothelial barrier function. Eur J Pharmacol 644:5\u20139","journal-title":"Eur J Pharmacol"},{"key":"9560_CR90","doi-asserted-by":"crossref","unstructured":"Fernandes S, Salta S, Bravo J, Silva A P, Summavielle T (2014). Acetyl-L-carnitine prevents methamphetamine-induced structural damage on endothelial cells via ILK-related MMP-9 activity. Mol Neurobiol","DOI":"10.1007\/s12035-014-8973-5"},{"key":"9560_CR91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-4827(03)00354-9","volume":"290","author":"T Ishizaki","year":"2003","unstructured":"Ishizaki T, Chiba H, Kojima T, Fujibe M, Soma T, Miyajima H, Nagasawa K, Wada I et al (2003) Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood\u2013brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res 290:275\u2013288","journal-title":"Exp Cell Res"},{"key":"9560_CR92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mvr.2010.10.004","volume":"81","author":"S Dohgu","year":"2011","unstructured":"Dohgu S, Takata F, Matsumoto J, Oda M, Harada E, Watanabe T, Nishioku T, Shuto H et al (2011) Autocrine and paracrine up-regulation of blood\u2013brain barrier function by plasminogen activator inhibitor-1. Microvasc Res 81:103\u2013107","journal-title":"Microvasc Res"},{"key":"9560_CR93","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","volume":"1","author":"I Juhan-Vague","year":"2003","unstructured":"Juhan-Vague I, Alessi MC, Mavri A, Morange PE (2003) Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 1:1575\u20131579","journal-title":"J Thromb Haemost"},{"key":"9560_CR94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12035-014-8837-z","volume":"52","author":"HM Ko","year":"2015","unstructured":"Ko HM, Lee SH, Kim KC, Joo SH, Choi WS, Shin CY (2015) The role of TLR4 and Fyn interaction on lipopolysaccharide-stimulated PAI-1 expression in astrocytes. Mol Neurobiol 52:8\u201325","journal-title":"Mol Neurobiol"},{"key":"9560_CR95","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1023\/A:1007015228318","volume":"20","author":"S Dohgu","year":"2000","unstructured":"Dohgu S, Kataoka Y, Ikesue H, Naito M, Tsuruo T, Oishi R, Sawada Y (2000) Involvement of glial cells in cyclosporine-increased permeability of brain endothelial cells. Cell Mol Neurobiol 20:781\u2013786","journal-title":"Cell Mol Neurobiol"},{"key":"9560_CR96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10571-006-9125-x","volume":"27","author":"F Takata","year":"2007","unstructured":"Takata F, Dohgu S, Yamauchi A, Sumi N, Nakagawa S, Naito M, Tsuruo T, Shuto H et al (2007) Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood\u2013brain barrier. Cell Mol Neurobiol 27:317\u2013328","journal-title":"Cell Mol Neurobiol"},{"key":"9560_CR97","first-page":"1267","volume":"50","author":"M Muzi","year":"2009","unstructured":"Muzi M, Mankoff DA, Link JM, Shoner S, Collier AC, Sasongko L, Unadkat JD (2009) Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans. J Nucl Med Off Publ Soc Nucl Med 50:1267\u20131275","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"9560_CR98","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1902\/jop.2009.090138","volume":"80","author":"A Gurkan","year":"2009","unstructured":"Gurkan A, Emingil G, Oktem G, Selvi N, Afacan B, Tunc I, Toz H, Atilla G (2009) Immunohistochemical analysis of inducible and endothelial forms of nitric oxide synthase in cyclosporin A-induced gingival overgrowth. J Periodontol 80:1638\u20131647","journal-title":"J Periodontol"},{"key":"9560_CR99","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/0886022X.2010.486487","volume":"32","author":"E Papachristou","year":"2010","unstructured":"Papachristou E, Papadimitropoulos A, Kotsantis P, Goumenos DS, Katsoris PG, Vlachojannis JG (2010) Interaction of endothelin-1 and nitric oxide pathways in human tubular epithelial cells under the influence of cyclosporine-A. Ren Fail 32:727\u2013732","journal-title":"Ren Fail"},{"key":"9560_CR100","first-page":"I214","volume":"114","author":"D Ramzy","year":"2006","unstructured":"Ramzy D, Rao V, Tumiati LC, Xu N, Miriuka S, Delgado D, Ross HJ (2006) Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation 114:I214\u2013I219","journal-title":"Circulation"},{"key":"9560_CR101","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2169\/internalmedicine.47.1042","volume":"47","author":"L Yang","year":"2008","unstructured":"Yang L, Yang XC, Yang JK, Guo YH, Yi FF, Fan Q, Liu XL (2008) Cyclosporin A suppresses proliferation of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Intern Med 47:1457\u20131464","journal-title":"Intern Med"},{"key":"9560_CR102","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1189\/jlb.0904503","volume":"77","author":"J Minguillon","year":"2005","unstructured":"Minguillon J, Morancho B, Kim SJ, Lopez-Botet M, Aramburu J (2005) Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. J Leukoc Biol 77:748\u2013758","journal-title":"J Leukoc Biol"},{"key":"9560_CR103","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1080\/14647270802336650","volume":"119","author":"R Kalayci","year":"2009","unstructured":"Kalayci R, Kaya M, Uzun H, Bilgic B, Ahishali B, Arican N, Elmas I, Kucuk M (2009) Influence of hypercholesterolemia and hypertension on the integrity of the blood\u2013brain barrier in rats. Int J Neurosci 119:1881\u20131904","journal-title":"Int J Neurosci"},{"key":"9560_CR104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)00460-8","volume":"686","author":"WG Mayhan","year":"1995","unstructured":"Mayhan WG (1995) Role of nitric oxide in disruption of the blood\u2013brain barrier during acute hypertension. Brain Res 686:99\u2013103","journal-title":"Brain Res"},{"key":"9560_CR105","first-page":"22","volume":"15","author":"MT Mohammadi","year":"2011","unstructured":"Mohammadi MT, Shid Moosavi SM, Dehghani GA (2011) Contribution of nitric oxide synthase (NOS) activity in blood\u2013brain barrier disruption and edema after acute ischemia\/reperfusion in aortic coarctation-induced hypertensive rats. Iran Biomed J 15:22\u201330","journal-title":"Iran Biomed J"},{"key":"9560_CR106","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/00207450490422821","volume":"114","author":"A Nukhet Turkel","year":"2004","unstructured":"Nukhet Turkel A, Ziya Ziylan Y (2004) Protection of blood\u2013brain barrier breakdown by nifedipine in adrenaline-induced acute hypertension. Int J Neurosci 114:517\u2013528","journal-title":"Int J Neurosci"},{"key":"9560_CR107","doi-asserted-by":"crossref","first-page":"H1598","DOI":"10.1152\/ajpheart.00490.2012","volume":"304","author":"PW Pires","year":"2013","unstructured":"Pires PW, Dams Ramos CM, Matin N, Dorrance AM (2013) The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 304:H1598\u2013H1614","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9560_CR108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.jcbfm.9600188","volume":"26","author":"R Poulet","year":"2006","unstructured":"Poulet R, Gentile MT, Vecchione C, Distaso M, Aretini A, Fratta L, Russo G, Echart C et al (2006) Acute hypertension induces oxidative stress in brain tissues. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 26:253\u2013262","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"9560_CR109","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.prp.2014.05.007","volume":"210","author":"MT Mohammadi","year":"2014","unstructured":"Mohammadi MT, Dehghani GA (2014) Acute hypertension induces brain injury and blood\u2013brain barrier disruption through reduction of claudins mRNA expression in rat. Pathol Res Pract 210:985\u2013990","journal-title":"Pathol Res Pract"},{"key":"9560_CR110","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1072-7515(03)00109-1","volume":"196","author":"C Wilasrusmee","year":"2003","unstructured":"Wilasrusmee C, Da Silva M, Siddiqui J, Bruch D, Kittur S, Wilasrusmee S, Kittur DS (2003) Role of endothelin-1 in microvascular dysfunction caused by cyclosporin A. J Am Coll Surg 196:584\u2013591","journal-title":"J Am Coll Surg"},{"key":"9560_CR111","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0012.2005.00357.x","volume":"19","author":"RL Cauduro","year":"2005","unstructured":"Cauduro RL, Costa C, Lhulier F, Garcia RG, Cabral RD, Goncalves LF, Manfro RC (2005) Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients. Clin Transpl 19:470\u2013474","journal-title":"Clin Transpl"},{"key":"9560_CR112","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1179\/016164101101199135","volume":"23","author":"T Arii","year":"2001","unstructured":"Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura KI, Katayama Y (2001) Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. Neurol Res 23:755\u2013760","journal-title":"Neurol Res"},{"key":"9560_CR113","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/01480541003642050","volume":"33","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kalonia H, Kumar A (2010) Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. Drug Chem Toxicol 33:377\u2013392","journal-title":"Drug Chem Toxicol"},{"key":"9560_CR114","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/01.STR.30.6.1279","volume":"30","author":"TJ Toung","year":"1999","unstructured":"Toung TJ, Bhardwaj A, Dawson VL, Dawson TM, Traystman RJ, Hurn PD (1999) Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats. Stroke J Cereb Circ 30:1279\u20131285","journal-title":"Stroke J Cereb Circ"},{"key":"9560_CR115","doi-asserted-by":"crossref","first-page":"1650S","DOI":"10.1093\/jn\/137.6.1650S","volume":"137","author":"RH Boger","year":"2007","unstructured":"Boger RH (2007) The pharmacodynamics of L-arginine. J Nutr 137:1650S\u20131655S","journal-title":"J Nutr"},{"key":"9560_CR116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.surg.2011.06.026","volume":"151","author":"A Puschel","year":"2012","unstructured":"Puschel A, Lindenblatt N, Katzfuss J, Vollmar B, Klar E (2012) Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation. Surgery 151:26\u201336","journal-title":"Surgery"},{"key":"9560_CR117","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.110.178095","volume":"337","author":"VL Chiasson","year":"2011","unstructured":"Chiasson VL, Quinn MA, Young KJ, Mitchell BM (2011) Protein kinase CbetaII-mediated phosphorylation of endothelial nitric oxide synthase threonine 495 mediates the endothelial dysfunction induced by FK506 (tacrolimus). J Pharmacol Exp Ther 337:718\u2013723","journal-title":"J Pharmacol Exp Ther"},{"key":"9560_CR118","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s12035-014-8954-8","volume":"52","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Dixit A, Singh A, Tripathi P, Singh D, Patel DK, Singh MP (2015) Cyclosporine A and MnTMPyP alleviate alpha-synuclein expression and aggregation in cypermethrin-induced Parkinsonism. Mol Neurobiol 52:1619\u20131628","journal-title":"Mol Neurobiol"},{"key":"9560_CR119","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuro.2010.10.006","volume":"32","author":"S Gottschalk","year":"2011","unstructured":"Gottschalk S, Cummins CL, Leibfritz D, Christians U, Benet LZ, Serkova NJ (2011) Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism. Neurotoxicology 32:50\u201357","journal-title":"Neurotoxicology"},{"key":"9560_CR120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mi.4.2.7","volume":"4","author":"NJ Serkova","year":"2004","unstructured":"Serkova NJ, Christians U, Benet LZ (2004) Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 4:97\u2013107","journal-title":"Mol Interv"},{"key":"9560_CR121","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10571-007-9209-2","volume":"27","author":"S Dohgu","year":"2007","unstructured":"Dohgu S, Nishioku T, Sumi N, Takata F, Nakagawa S, Naito M, Tsuruo T, Yamauchi A et al (2007) Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro. Cell Mol Neurobiol 27:889\u2013899","journal-title":"Cell Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9560-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9560-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:25:26Z","timestamp":1718241926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9560-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,14]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9560"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9560-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,14]]}}}